AMRN Amarin

Watchlist

0.542
-0.009-1.65%

Close Feb 28 16:00 ET

0.553
+0.011+2.03%

Post 19:54 ET

222.90MMarket Cap-5.42P/E (TTM)

About Amarin Company

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Company Profile

SymbolAMRN

Company NameAmarin

Listing DateApr 1, 1993

Issue Price6.00

Founded1989

CEOMr. Aaron D. Berg

MarketNASDAQ

Employees275

Securities TypeDR

ADS Ratio1.0 : 1.0

Fiscal Year Ends12-31

AddressIconic Offices, The Greenway,Block C Ardilaun Court, 112–114,St. Stephens Green

CityDublin

ProvinceDublin

CountryIreland

Zip Code2

Phone353-1-6699-020

Websitehttp://www.amarincorp.com

Company Executives

Name
Position
Salary

Aaron D. Berg
Director, President and Chief Executive Officer
2.45M

Peter Fishman
Chief Financial Officer and Principal Accounting Officer
--

Dr. Steven B. Ketchum, PhD
Executive Vice President, President, Research and Development and Chief Scientific Officer
2.35M

Jonathan N. Provoost
Executive Vice President, Chief Legal and Compliance Officer and Secretary
659.26K

Dr. Odysseas D. Kostas, M.D.
Chairman of the Board
650.41K

Dr. Paul Cohen, M.D.
Independent Director
622.06K

Patrice Bonfiglio
Independent Director
626.87K

Mark DiPaolo, Esq.
Independent Director
621.00K

Diane E. Sullivan
Independent Director
630.83K

Oliver O'Connor
Independent Director
611.85K

Keith L. Horn
Independent Director
632.09K

Louis Sterling, III
Independent Director
629.35K

AMRN Amarin

About Amarin Company

Company Profile

Company Executives

Trending Stocks